Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm

Int J Lab Hematol. 2015 Dec;37(6):e150-2. doi: 10.1111/ijlh.12398. Epub 2015 Jun 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chromosome Aberrations
  • Drug Resistance, Neoplasm / genetics
  • Female
  • Humans
  • Immunophenotyping
  • Janus Kinase 2 / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Myeloproliferative Disorders / diagnosis*
  • Myeloproliferative Disorders / genetics*
  • Receptors, Thrombopoietin / genetics*
  • Treatment Outcome

Substances

  • Receptors, Thrombopoietin
  • MPL protein, human
  • Janus Kinase 2